| Product dosage: 180mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.37 | $101.03 (0%) | 🛒 Add to cart |
| 60 | $2.70 | $202.07 $162.05 (20%) | 🛒 Add to cart |
| 90 | $2.49 | $303.10 $224.07 (26%) | 🛒 Add to cart |
| 120 | $2.37 | $404.13 $284.09 (30%) | 🛒 Add to cart |
| 180 | $2.26 | $606.20 $406.13 (33%) | 🛒 Add to cart |
| 270 | $2.19
Best per pill | $909.30 $590.19 (35%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.02 (0%) | 🛒 Add to cart |
| 90 | $0.78 | $73.52 $70.02 (5%) | 🛒 Add to cart |
| 120 | $0.76 | $98.03 $91.03 (7%) | 🛒 Add to cart |
| 180 | $0.73 | $147.05 $132.04 (10%) | 🛒 Add to cart |
| 270 | $0.72 | $220.57 $195.06 (12%) | 🛒 Add to cart |
| 360 | $0.71
Best per pill | $294.10 $257.08 (13%) | 🛒 Add to cart |
Similar products
More info:
diltiazem
Diltiazem hydrochloride represents one of those fascinating calcium channel blockers that fundamentally changed how we approach cardiovascular management. When I first encountered it during my cardiology rotation back in ‘98, we were still heavily reliant on verapamil for rate control, but diltiazem offered this beautiful balance between vascular selectivity and cardiac effects that made it particularly useful for patients with comorbid conditions. The crystalline powder we’d compound in hospital pharmacy has evolved into sophisticated extended-release formulations, but the core mechanism remains elegantly simple - blocking L-type calcium channels in vascular smooth muscle and cardiac cells.
adalat
Nifedipine, marketed under the brand name Adalat among others, is a calcium channel blocker medication primarily used in the management of hypertension and angina. It belongs to the dihydropyridine class and functions by relaxing blood vessels, thereby reducing blood pressure and improving blood flow to the heart muscle. The development of nifedipine represented a significant advancement in cardiovascular pharmacotherapy, offering an alternative mechanism of action to beta-blockers and diuretics. Its introduction in the 1970s revolutionized angina management, particularly for vasospastic angina where traditional antianginals often proved inadequate.
aricept
Donepezil hydrochloride, marketed under the brand name Aricept, is a centrally acting, reversible acetylcholinesterase inhibitor. It’s specifically indicated for the symptomatic treatment of mild to moderate Alzheimer’s disease. This isn’t a dietary supplement or a device; it’s a prescription pharmaceutical that directly targets the cholinergic deficit widely recognized as a core pathological feature in Alzheimer’s dementia. Its development was a significant step forward in the 1990s, offering the first real pharmacological hope for slowing the cognitive decline in a condition that had been largely untreatable.
buspar
Buspirone hydrochloride, marketed under the brand name Buspar among others, represents a distinct class of anxiolytic medication known as an azapirone. Unlike the benzodiazepines that dominated anxiety treatment for decades, Buspar offers a non-sedating, non-addictive pharmacological profile, acting as a partial agonist primarily at the 5-HT1A serotonin receptors. Its development was a deliberate move away from the GABAergic system to avoid the dependence and cognitive impairment associated with its predecessors. In clinical practice, we’ve found it fills a crucial niche, particularly for patients where the risk of dependence is a significant concern or for those who have not tolerated SSRIs.
bystolic
Bystolic represents one of those interesting cases where a beta-blocker managed to distinguish itself in a crowded therapeutic class. Known generically as nebivolol, this medication occupies a unique position in cardiovascular management due to its distinctive pharmacological profile that combines beta-1 selectivity with nitric oxide-mediated vasodilation. Unlike traditional beta-blockers that often cause peripheral vasoconstriction and cold extremities, Bystolic offers hemodynamic benefits that make it particularly valuable in hypertension management. Bystolic: Advanced Blood Pressure Control with Vasodilatory Benefits 1.
calan
Calan represents one of those interesting cases where an established cardiovascular medication found surprising applications in neurological and metabolic contexts. Originally developed as a calcium channel blocker for hypertension and angina, we’ve observed some fascinating off-label responses that deserve documentation. ## 1. Introduction: What is Calan? Its Role in Modern Medicine Calan, known generically as verapamil, belongs to the phenylalkylamine class of calcium channel blockers. It’s primarily prescribed for managing hypertension, angina pectoris, and certain cardiac arrhythmias.
Cardizem: Effective Blood Pressure and Heart Rhythm Control - Evidence-Based Review
Cardizem, known generically as diltiazem, is a calcium channel blocker primarily prescribed for managing cardiovascular conditions like hypertension, chronic stable angina, and certain arrhythmias. It functions by relaxing blood vessels and reducing the heart’s workload, which helps lower blood pressure and improve blood flow to the heart muscle. Available in various formulations, including immediate-release tablets, extended-release capsules, and intravenous forms, Cardizem is a cornerstone in cardiology due to its efficacy and relatively favorable side effect profile.
digoxin
Digoxin, a cardiac glycoside derived from the foxglove plant (Digitalis lanata), represents one of medicine’s oldest yet most complex pharmacological tools. For over 200 years, this compound has maintained a precarious but essential position in our cardiovascular arsenal, balancing narrow therapeutic windows with profound clinical benefits when used correctly. What fascinates me isn’t just its mechanism—which we’ll explore—but the delicate clinical dance required to harness its benefits while avoiding its considerable risks.
Dutas: Comprehensive DHT Suppression for BPH and Hair Loss - Evidence-Based Review
Dutasteride, marketed under brand names including Dutas, is a potent 5α-reductase inhibitor primarily used in clinical practice for managing benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern hair loss). Unlike finasteride which only inhibits type II 5α-reductase, dutasteride provides dual inhibition of both type I and type II isoforms, resulting in more comprehensive suppression of dihydrotestosterone (DHT) conversion from testosterone. This pharmaceutical agent represents a significant advancement in endocrine-targeted therapy, particularly for conditions driven by androgen-mediated tissue growth.